CIK 0001716947 · Non-accelerated filer<br>Smaller reporting company
Ensysce Biosciences, Inc.
Sign in to watch- Ticker
- ENSC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822755287
- Phone
- (858) 263-4196
- Business address
- 7946 IVANHOE AVENUE, SUITE 201, LA JOLLA, CA, 92037
- Former names
- Leisure Acquisition Corp.
- DEF 14A Proxy Proxy Statement
- S-3/A Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-A12G/A Other 8-A12G/A
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Other events
- SC 13G Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 4 Open-market buy Director bought 357,143 shares at $1.40 ($500,000)
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-A12G Other 8-A12G
- 8-K Event Delisting notice
- S-3 Offering Registration Statement
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- S-3 Offering Registration Statement
Page 10 of 28 · 550 filings